Synopsys, Inc. (Nasdaq: SNPS) appoints Luis Borgen and Marc Casper to its board of directors. Luis most recently served as CFO of athenahealth, Inc., while Marc is currently the chairman, president and CEO of Thermo Fisher Scientific, Inc.
“Luis and Marc are accomplished business leaders with operational and strategic experience and vision that will bring substantial value to the strong board we have at Synopsys,” said Aart de Geus, chairman and CEO of Synopsys. “We are excited to incorporate their thinking and complementary perspectives as we scale Synopsys to $5 billion and beyond, delivering the next level of impact for the benefit of our customers, shareholders, partners and employees.”
Marc, a US Air Force veteran, has spent over 25 years as a corporate finance expert. This includes 12 years in the CFO of various industries. Before athenahealth, he served as the CFO at Vistaprint, DAVIDsTEA, Inc. and DaVita, while currently serves on the boards of Carters, Inc and Eastern Bankshares Inc.
“It is a privilege to join the board of Synopsys and address some of the biggest technical challenges in the world today,” said Borgen. “Synopsys has an unmatched product portfolio that enables a new ‘smart everything’ era, and I look forward to partnering with the board and the leadership team to continue revolutionizing chip design.”
Marc has served as an executive at Thermo Fisher for over two decades, becoming CEO and president in 2009, and chairman in 2020. Before Thermo Fisher, he was the CEO of Kendro Laboratory Products Ltd., and president Americas at Dade Behring.
“I’m honored to join the board of Synopsys and excited for the opportunities ahead,” said Casper. “Synopsys has a great track record of innovation across the industry, and I look forward to working with the board and company leadership to continue to advance this important work.”
